EGFR and glioblastoma: In glioblastoma, the mutations alter EGFR dimer formation, attenuating ligand bias, corrupting downstream signaling.408 Mutations that alter the transcriptional landscapes, perturb the protein interactome,409,410 increase cancer heterogeneity and aggressiveness.